Sera Prognostics (SERA) Net Margin Growth (1y) (2021 - 2026)

Sera Prognostics (SERA) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Abbott Laboratories 180.89 Bn 173.59 Bn 6.27 Bn -314.00
2 Stryker 127.82 Bn 124.94 Bn 3.81 Bn 123.00
3 Medtronic 107.49 Bn 98.27 Bn 6.41 Bn 94.00
4 Boston Scientific 67.24 Bn 65.78 Bn 3.61 Bn 1,132.00
5 Edwards Lifesciences 48.02 Bn 44.34 Bn 1.29 Bn -
6 Dexcom 28.25 Bn 27.14 Bn 750.30 Mn 656.00
7 GE HealthCare Technologies 28.17 Bn 25.89 Bn 1.98 Bn -430.00
8 Smith & Nephew 26.72 Bn 26.14 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn 201.00
10 Sera Prognostics 103.03 Mn 103.03 Mn -28,000.00 -5.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.52 Mn
Dec 31, 2025 -1.09 Mn
Sep 30, 2025 -5.05 Mn
Jun 30, 2025 -3.64 Mn
Dec 31, 2024 -2.08 Mn
Sep 30, 2024 -995,394.00
Jun 30, 2024 -2.71 Mn
Dec 31, 2023 -224,949.00
Sep 30, 2023 -575,181.00
Jun 30, 2023 592,411.00
Mar 31, 2023 2.14 Mn
Dec 31, 2022 3.22 Mn
Sep 30, 2022 3.01 Mn
Jun 30, 2022 2.16 Mn
Mar 31, 2022 2.34 Mn
Dec 31, 2021 4.03 Mn
Sep 30, 2021 5.84 Mn
Jun 30, 2021 4.14 Mn